ArticleTherapeutic advances in medical oncology2022

First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial.

Sonja Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.